IBT Press Releases
You can also visit the market news section of the London Stock Exchange website to view IBT press releases including NAV releases.
2010
- 15 February 2010 - Portfolio Company Update - Archemix
- 12 January 2010 - Interim Management Statement
- 7 January 2010 - Portfolio Company Update - EUSA Pharmaceuticals
2009
- 14 December 2009 - Portfolio Update - New Unquoted Investment Ophthotech Corp
- 27 November 2009 - Portfolio Update - Ikano Therapeutics
- 24 November 2009 - Portfolio Update - EBR Systems
- 23 November 2009 - Portfolio Update - Oxagen
- 20 November 2009 - Annual Information Update
- 17 November 2009 - Portfolio Company Update - Affinium Pharmaceuticals
- 16 November 2009 - Portfolio Company Update - Entellus Medical
- 9 November 2009 - Portfolio Company Update - Allocure
- 5 November 2009 - Portfolio Company Update - Delenex Therapeutics
- 2 November 2009 - Portfolio Company Update - Ricerca
- 30 October 2009 - Voting Rights and Capital
- 26 October 2009 - Portfolio Company Update - Itero Pharmaceuticals Oxagen and Ricerca
- 23 October 2009 - Annual Reports & Accounts
- 19 October 2009 - Portfolio Company Update - Lux Biosciences
- 7 October 2009 - Portfolio Company Update - TransEnterix
- 30 September 2009 - Portfolio Update - Lux Biosciences
- 28 September 2009 - Portfolio Update - Entellus
- 14 September 2009 - Portfolio Update - Alcon to Acquire Swiss Biotechnology Firm, ESBATech AG
- 28 August 2009 - Portfolio Update - Archemix
- 27 August 2009 - Portfolio Company Update
- 26 August 2009 - Portfolio Company Update
- 7 August 2009 - Appointment of Director
- 3 August 2009 - Portfolio Company Update - Cadent
- 17 July 2009 - Portfolio Company Update - Ricerca Biosciences
- 9 July 2009 - Interim Management Statement for the Quarter ended 31 May 2009
- 2 July 2009 - Portfolio Company Update - Itero Pharmaceuticals
- 9 June 2009 - Portfolio Company Update - Micromet
- 3 June 2009 - Portfolio Company Update - Lux Biosciences
- 1 June 2009 - Follow on investment in the UK based unquoted portfolio company RespiVert - Lux Biosciences
- 11 May 2009 - VNUS Medical Technologies announced it had signed a definitive agreement with Covidien
- 24 April 2009 - Revalution of unquoted portfolio company - Ricerca Biosciences
- 20 April 2009 - IBT Interim Results
- 6 April 2009 - Follow on investment in the unquoted portfolio company ESBATech.
- 2 March 2009 - Change of Company Secretary and Registered Office
- 19 February 2009 - Investment in unquoted portfolio company TransEnterix Inc.
- 11 February 2009 - Revaluations of unquoted portfolio company Cadent
- 6 February 2009 - Revaluations of unquoted portfolio companies Affibody, Dynogen, Ricerca and Intranasal
- 26 January 2009 - Interim Management Statement
Click here for IBT press releases from 2001 - 2008
You will need Adobe Acrobat Reader to view these PDF files. If you do not have this software installed on your computer, you can download it free from the Adobe website.